Care Line Live is an award-winning revolutionary monitoring and management platform for Home Care Agencies. CLL is a client-based system that enables home care agencies to run their businesses from any place. It reduces administration, automates processes, easily rosters client visits and improves efficiency and productivity by giving the client more Time to Care. It increases client and carer satisfaction, provides accessible and responsive support, increases compliance for CQC purposes, generates higher profits through improved efficiency and capacity. The future product road map includes integration with 3rd party home automation platforms that will allow home care agencies to offer further services to their clients, such as secure key-less entry.
days to go:
Expired
investment:
£367,000
CareGREEN is an innovation company that has created a unique air pollution capture and storage technology with the aim to reduce harmful pollution in the atmosphere. Their latest product is the Environmental Air Purification Intervention & Control System (EAPICS). The technology has been accredited as a significant solution in reducing COx worldwide. A World Health Organisation (2016) report established that more than 80% of people living in urban areas face the greatest environmental risk to their health today due to air pollution. CareGREEN believes its specialised filtration systems will contribute to a considerable fall in health issues linked to poor air quality. It is also diversifying its reach in other renewable energy sectors such as solar and wind. The company will utilise the investment to scale its business.
days to go:
Expired
investment:
Withheld
Ceryx Medical is a medical technological entity that is developing bioelectronics based on a unique, patent-protected, chip technology that can mimic nerve centres within the body called Central Pattern Generators (CPGs). CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate, and even walking. The Ceryx system resembles a traditional cardiac pacing device that holds a lot of promise in potentially alleviating incidences of heart failure leading to a therapeutic effect on patient health. In the UK, this is a day surgery procedure under local anaesthetic with a basic system costing around £3500. The device, therefore, offers a cost-effective, single procedure solution for this currently intractable disease. Treatment expenditures on heart failure cases in the EU amount to almost £35 billion. The Ceryx system is a potential disruptor in this segment and offers multiple potential applications. The company is targeting £500,000 as part of £1 million round. With the investment, the company aims to produce a data package that mimics those used to support 510k/NDA applications, as mandated by the US Food and Drug Administration (FDA), for current devices and drugs used to treat heart failure.
days to go:
Expired
investment:
Withheld
Targeting heavy-duty diesel engines the Cibus21 retrofit technology system claims it is fuel-saving and reduces harmful exhaust emissions through the principle of Enhanced Combustion. With patents pending the company claims the enhanced combustion process introduces small amounts of LPG directly into the diesel engines' air intake to fundamentally change the chemistry of the combustion process. The company states that the current experienced efficiency gains are 15-20% reduced in diesel use and CO2 emissions.
days to go:
Expired
investment:
£116,000
The OpClear helps to keep the image clear and the surgeon relaxed and focused during laparoscopy.
days to go:
Expired
investment:
£1,933,449
Cipher Surgical have developed a new product that is designed to remove contaminants from the laparoscope’s lens during keyhole surgery, thus removing the need to constantly take the laparascope out of the patient for cleaning. This is done by manipulating CO2 and saline across the lens and therefore removing blood, peritoneal fluid, particulate matter and condensation/fogging from the lens.
days to go:
Expired
investment:
£175,000
Close Shave Society (CSS) offers an alternative to the expensive and often frustrating task of purchasing razor blades by providing high quality razors for half of the cost. The Society achieves this through sourcing the blades directly from the premium quality German manufacturer partners of the company, which means skipping the middle man, and passing these savings on to the customer.
days to go:
Expired
investment:
£18,155
An online comparison portal focusing on financial, insurance and utility products serving the Latin American market.
days to go:
Expired
investment:
£288,620
days to go:
Expired
investment:
£337,700
Co-Space is a forward-thinking flexible office operator with a focus on affluent towns and cities outside Central London. Established in 2018, Co-Space has thrived even during the pandemic, boasting two successful sites in Reading (95% occupied) and Stevenage (93% occupied). Our approach involves transforming underutilized spaces into highly sought-after flexible offices, incorporating exceptional interior design and dedicated service. With a revenue run rate of £1.5 million and over 90% of it being contracted and recurring, Co-Space is a promising contender, bridging the gap between exceptional London design and regional competition.
days to go:
Expired
investment:
£50,000
